🇺🇸 FDA
Patent

US 9243051

Monomeric recombinant MHC molecules useful for manipulation of antigen-specific T-cells

granted A61KA61K39/0008

Quick answer

US patent 9243051 (Monomeric recombinant MHC molecules useful for manipulation of antigen-specific T-cells) held by United States Government as represented by the Department of Veterans Affairs expires Mon Jan 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States Government as represented by the Department of Veterans Affairs
Grant date
Tue Jan 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K39/0008